In addition, 834 differential m6A-methylated genes in the BMSCs were identified in the T2DM group when compared with the control; of which 43 were m6A hypermethylated genes (including those in ZNF12, MAFK, NCOA7, EPB41L3, and TIFA) and 790 were m6A hypomethylated genes (including those in TM4SF1, PRPSAP1, OTUD5, GTPBP4, and TAF3). This evidence concerns the gene ZNF12 and type 2 diabetes mellitus.